Home

arrow iconNewsarrow iconarrow icon

INVO Fertility, Inc. Announces WFI Clinic Joined the Progyny Network to Expand Patient Access

INVO Fertility, Inc. Announces WFI Clinic Joined the Progyny Network to Expand Patient Access

INVO Fertility, Inc has confirmed that its Wisconsin Fertility Institute-WFI clinic joined the Progyny network, making advanced reproductive care more widely available and accessible for more patients seeking fertility treatment.

By FertilityIn

11 May 2026

3 min read

Invo Logo

Invo Logo

INVO Fertility, Inc., a fertility company that seeks to make advanced reproductive care more available by opening, buying, and running fertility clinics and related businesses and technologies, says that its Wisconsin Fertility Institute-WFI clinic joined the Progyny network.


Progyny offers fertility and family-building advantages to about 7.2 million people through more than 600 employers and plan sponsors across the country. WFI's potential market in Wisconsin and the neighbouring areas is bigger now that it is part of the Progyny network. This arrangement makes it much easier for the clinic to visit patients whose companies cover them.


Patients who meet the requirements can now get all of WFI's reproductive services, including diagnostic testing, in vitro fertilisation (IVF), fertility preservation, and other advanced treatment options, all through their network. Progyny's scientifically integrated benefit design makes it easier for patients to keep track of their money and paperwork. The program decreases barriers to care and helps people use therapy more effectively and receive better results. Progyny is a big part of the fertility business because it helps patients with the two biggest problems they have: getting care and paying for it.


As the WFI clinic joined the Progyny network, it improved its mix of third-party payers from a business point of view and lets it help more people who require care. As more and more companies offer reproductive benefits, it is becoming more and more necessary to work with the best fertility benefits administrators to promote organic growth.


Employer-sponsored fertility benefits are one of the fastest-growing parts of healthcare benefits. Companies want to hire and keep the best workers, so they offer these benefits. INVO Reproductive believes that making its services easier to find on well-known national benefit platforms will help it stay competitive and assist its increasing network of reproductive centres to grow even further. The company sees the move as a big step forward and an important part of its overall plan to grow its clinic platform, build stronger relationships with payers, and improve its long-term financial performance.


According to COO of INVO Fertility, April McGhee, “We are excited to join the Progyny network, a leader in fertility benefits known for its commitment to transparency, exceptional client and member satisfaction, and superior clinical outcomes." This partnership expands access to high-quality fertility treatment for more patients while reinforcing our focus on delivering exceptional results and a seamless, supportive care experience. We look forward to helping Progyny members build their families with confidence.”


Steve Shum, CEO of INVO Fertility, says that “This relationship expands our addressable patient base and strengthens our access to employer-sponsored demand." “As we continue to grow through strategic clinic development and acquisitions, establishing relationships with leading benefits providers like Progyny represents a further enhancement to our growth objectives, operating leverage, and ability to drive long-term value creation for our shareholders.”

28 views

Share

FertilityIn

Send Enquiry for this Story

Previous News

Simbryo FX Personalized Assay Redefines IVF Success by Measuring Endometrial Fertility

Next News

IVF CRYO Calls for Enhanced Protocols in Better Safe Embryos and Eggs Shipping Nationwide

Related Articles

Sapyen Partners with My Surrogacy Journey to Enhance Fertility Testing and Reproductive Health Services Across the U.S.

Sapyen Partners with My Surrogacy Journey to Enhance Fertility Testing and Reproductive Health Services Across the U.S.

apyen, a global leader in male fertility diagnostics, has entered a strategic partnership with My Surrogacy Journey to broaden fertility testing and reproductive health support for intended parents across the United States. The collaboration covers semen analysis, DNA fragmentation testing, and infectious disease screening, with plans for international expansion.

ART

1 min read

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Genetic Optimization Demand Expands

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Genetic Optimization Demand Expands

Nucleus Genomics has announced that the Fertility Institute of Hawaii Joins Nucleus IVF+ network, bringing advanced carrier and embryo screening to Hawaii's largest IVF practice. The partnership expands genetic optimization access across the Pacific, with risk reduction data covering endometriosis, heart disease, breast cancer, type 1 diabetes, and Alzheimer's disease.

ART

1 min read

Taiwan Pioneers AI-Powered Embryo Selection Model, Improving Chromosomally Normal Embryo Identification Rate by Up to 24%

Taiwan Pioneers AI-Powered Embryo Selection Model, Improving Chromosomally Normal Embryo Identification Rate by Up to 24%

TFC Taipei Fertility Center has introduced an AI-Powered Embryo Selection model that improves chromosomally normal embryo identification by up to 24%. Presented at ASPIRE 2026, the iDAScore v2.0 system brings precision and objectivity to IVF treatment, reducing implantation failure risk and shortening time to conception for infertile patients.

ART

1 min read

CDT Equity Completes Global Patent Coverage for AZD5904 in Male Infertility Following Canadian Grant

CDT Equity Completes Global Patent Coverage for AZD5904 in Male Infertility Following Canadian Grant

CDT Equity Inc. (Nasdaq: CDT) has announced the Canadian patent grant for AZD5904 in male infertility, completing approval across all key pharmaceutical target markets. The milestone strengthens CDT's IP position for the AstraZeneca-licensed Myeloperoxidase inhibitor as the company advances active out-licensing and strategic partnering discussions for the asset.

ART

1 min read

Nucleus IVF+ Joins SCRC to Bring Genetic Optimization to One of America's Most In-Demand Fertility Centers

Nucleus IVF+ Joins SCRC to Bring Genetic Optimization to One of America's Most In-Demand Fertility Centers

Nucleus Genomics has announced that Nucleus IVF+ joins SCRC, the Southern California Reproductive Center, as part of its rapidly expanding global network. The partnership integrates advanced carrier screening and embryo analysis across SCRC's four California locations, serving thousands of patients annually across Beverly Hills, Santa Barbara, Pasadena, and Ventura.

ART

1 min read

UNC Fertility Sets Strategic Collaboration with IVI RMA North America to enhance Patient Care and Clinical Excellence

UNC Fertility Sets Strategic Collaboration with IVI RMA North America to enhance Patient Care and Clinical Excellence

UNC Fertility has announced its plans for Collaboration with IVI RMA North America to bring best clinical and operational best practices across the region, expanding access to cutting-edge fertility treatments and research.

ART

1 min read

AI-Powered Embryo Assessment Gets FDA Green Light as Alife Health Clears Regulatory Milestone

AI-Powered Embryo Assessment Gets FDA Green Light as Alife Health Clears Regulatory Milestone

Alife Health has secured FDA clearance for Embryo Predict, its AI-powered embryo assessment tool for IVF. Backed by a 440-patient, seven-center randomized clinical trial, the platform delivers data-driven embryo selection insights to embryologists across the U.S., Europe, and the U.K., addressing longstanding variability in clinical decision-making.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address